Molecular Mechanisms Associated with Breast Implant Complications

M
Mithun Sinha

Primary Investigator

Enrolling By Invitation
18 years - 100 years
Female
Phase N/A
500 participants needed
5 Locations

Brief description of study

In recent years, many complications have been attributed to breast implants including chronic fatigue and other symptoms associated with autoimmune diseases, called Breast Implant Illness (BII). Some women have even developed a rare type of T-cell non-Hodgkin’s lymphoma around their breast implants, called BIA-ALCL. Hundreds of women have been affected by BII/BIAALCL and many have lost their lives to BIA-ALCL. Most of the scientific literature addressing breast implant associated complications focuses on implant materials despite the fact that silicone – the material used in implants – has been proven to be safe in multiple studies. This is why more research is needed to understand other factors that may be contributing to breast implant complications.

Detailed description of study

Researchers will collect a blood sample as well as the surgically discarded specimens which would be disposed as medical waste. Researchers will also collect information from participants' medical record, and participants will complete a questionnaire.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Breast Implant
  • Age: 18 years - 100 years
  • Gender: Female

Individuals at least 18 years of age undergoing removal of a breast implant.
Individuals with HIV or currently taking immunosuppressive medications will not be eligible.
Women who are pregnant will not be eligible.

Updated on 01 Aug 2024. Study ID: 2003674175
Please visit our main page to search for other studies you may be interested in. If you need help finding a study or have any questions, please contact us at inhealth@iu.edu

Interested in the study?

This study is accepting only persons who receive care at a certain clinic or doctor or who are part of an invited group. Questions about this study can be directed to the study team listed in the description or contact your doctor to see if you are eligible.

Accepting referrals by invitation only